KUALA LUMPUR, 4 Feb 2026 — Health Minister YB Datuk Seri Dr Dzulkefly Ahmad today unveiled the NCSM–PDHS VALENS Support Fund, a patient support initiative. The fund was established through a collaboration between The National Cancer Society of Malaysia (NCSM) and Pharm-D Health Science (PDHS).
Established through a collaboration between the National Cancer Society of Malaysia (NCSM) and Pharm-D Health Science (PDHS), the Support Fund aims to strengthen cancer care through improved access to specialised nutrition product support, education and awareness.
Observed globally on 4 February under the theme United by Unique, the World Cancer Day highlights the importance of recognising each individual’s unique cancer journey. In Malaysia, the observance aligns with national efforts to strengthen cancer prevention, early detection, access to care, and sustainable patient support.
The NCSM–PDHS VALENS Support Fund is grounded in three core principles: Accessibility, Sustainability, and Transparency. These principles are closely aligned with the theme of World Cancer Day, United by Unique, which recognises that every patient’s cancer journey is different and requires tailored support.
The Fund ensures that underserved cancer patients have equitable access to specialised nutritional product support1, which is essential for improving treatment tolerance, recovery and quality of life. By addressing financial barriers, the Fund ensures that no patient is left behind, reflecting World Cancer Day’s call to recognise each individual’s unique needs.
As part of the Fund’s immediate and tangible support, Pharm-D Health Science has committed to donating 1,000 cans of VALENS Onthera+, a specialised immunonutrition formula, through the initiative Onthera+ 1,000 Cans of Hope. This contribution represents a concrete expression of the Fund’s purpose, which offers specialised nutritional support to cancer patients in need.
Pharm-D Health Science reinforces long-term sustainable support by allocating a portion of Pharm-D Health Science’s VALENS specialised nutrition product sales to NCSM under this fund arrangement. This structured and sustainable approach ensures continuity beyond one-off contributions and strengthens nutritional care in the cancer journey.
Transparency underpins responsible governance. By implementing structured fund management, phased support delivery, utilisation tracking, and impact monitoring, the Fund ensures accountability and delivers measurable impact.
Beyond direct patient support, the collaboration also places strong emphasis on awareness and education initiatives led by NCSM to empower patients, caregivers, and communities with the knowledge to navigate cancer prevention, treatment, and survivorship.
According to the President of National Cancer Society Malaysia (NCSM), Dato’ Dr. Saunthari Somasundaram, the initiative reflects a holistic approach to cancer care,
“Cancer care is not defined solely by treatment protocols, it is about ensuring that patients are supported holistically, with dignity, knowledge, and access to essential resources. The NCSM–PDHS VALENS Support Fund reflects a values-driven partnership that prioritises accessibility, sustainability, and transparency, while strengthening patient education and long-term support for those who need it most.”
Meanwhile, Group Managing Director of Pharm-D Health Science, Wong Chin Cheang said the initiative reflects the organisation’s broader responsibility to contribute to national health priorities:
“As a home-grown company, we believe our role extends beyond developing health solutions to actively supporting the communities we serve. This Fund represents a long-term commitment to patient wellbeing, where access to specialised nutrition, education, and sustainable support come together to create real, measurable impact in cancer care for the patients and families in Malaysia.”
The World Cancer Day 2026 programme hosted by NCSM, convened national stakeholders in support of a more inclusive and sustainable cancer care ecosystem.
Initiatives such as the NCSM–PDHS Valens Support Fund represent a significant step forward in improving access to long-term, measurable support for cancer patients, while reinforcing the role of specialised nutrition and education as vital components of comprehensive cancer care in Malaysia. Beyond providing tangible support, the Fund embodies the spirit of United by Unique, championing personalised, sustainable and inclusive cancer care across Malaysia.
References
- Khidzir, Zakwan. 2025. “The Crucial Role of Nutrition in Cancer Care.” Cancer Matters (National Cancer Society of Malaysia). September 3, 2025. https://cancermatters.cancer.org.my/2025/09/03/the-crucial-role-of-nutrition-in-cancer-care/.
About National Cancer Society Malaysia (NCSM)
The National Cancer Society of Malaysia (NCSM) is Malaysia’s first non-profit cancer organisation that provides education, care, and support services for cancer patients. Over the last 58 years, it has provided comprehensive assistance to patients and caregivers. NCSM helps patients understand and cope with cancer at various stages through its Cancer and Health Screening Clinic, Nuclear Medicine Centre, Resource and Wellness Centre, Adult’s Home of Hope, and Children’s Home of Hope.
To learn more about NCSM, please visit www.cancer.org.my
About Pharm-D Health Science (PDHS)
Founded in 2001, Pharm-D Health Science (PDHS) is a pharmaceutical and consumer health company specialising in specialised medicines, pharmaceuticals, healthcare and consumer health products. With a steadfast commitment to pioneering research, development, and manufacturing, PDHS offers a comprehensive array of solutions, including medications, over-the-counter medications, specialised nutrition, health supplements, and medical devices. Notably, PDHS is also a pioneer in postbiotics research and supply in Malaysia.
Beyond pharmaceuticals, the company provides healthcare and consumer health solutions under trusted house brands such as VALENS, ELDON, Lang Bragman, MedSkin, Reflux-G, Retane, and more. Ultimately, Pharm-D Health Science’s dedication to scientific excellence and holistic healthcare is driven by the mission to make health and wellbeing accessible for all with science.
For media enquiries:
Corporate Communications Department
Email: communications@pharmdhs.com
Tel: +603-7770 7918
